2024 DIR Changes May Bring Financial Challenges to Independent Pharmacies
Pharmacy Times
JUNE 26, 2023
Pharmacies should start to prepare for cash flow challenges when the direct and indirect remuneration changes in 2024.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmacy Times
JUNE 26, 2023
Pharmacies should start to prepare for cash flow challenges when the direct and indirect remuneration changes in 2024.
Drug Topics
MARCH 11, 2024
A panel discussion at the Outcomes 2024 SYNC National Conference touched upon many important themes in community pharmacy, including the evolving role of pharmacists, emerging tech, and key challenges going forward.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 12, 2023
New DIR fee rules eliminate clawbacks, but may create cashflow challenges for pharmacies in the first half of 2024.
Hospital Pharmacy Europe
FEBRUARY 8, 2024
Tiene Bauters, PharmD PhD, Pharmacy Department , Ghent University Hospital in Belgium, offers her take on what’s hot on the horizon for hospital pharmacy in 2024. Uptake to enhance efficiency and streamline pharmacy operations is becoming increasingly common.
Digital Pharmacist
APRIL 25, 2023
f you’re an independent pharmacy owner or pharmacist, you’re probably aware of the upcoming changes to DIR fees that will take effect in 2024. In this blog post, we will discuss the evolution of DIR fees leading up to the DIR fee changes coming in 2024, and the pros and cons independent pharmacies owners should prepare for.
IDStewardship
OCTOBER 18, 2023
Candidate 2024 & Lucas Zhou, Pharm.D. Candidate 2024 Article Posted October 2024 Hello Readers of IDstewardship! My name is Eisha Ludtke, and I am a 4th year pharmacy student at the University of Florida (UF). Written By: Eisha Ludtke, Pharm.D.
PQA
APRIL 5, 2024
The 2024 PQA Annual Meeting is less than six weeks away, and we are excited to welcome you all back to Baltimore! We also highlight two important, just released CMS policies and our members' perspectives pharmacy deserts and specialty pharmacy. Tuesday, April 9, is the final day to take advantage of the PQA hotel discount.
PQA
JANUARY 26, 2024
We also highlight our members' perspectives on health equity, the role of managed care, access and affordability in specialty pharmacy. Explaining the Role of Managed Care Pharmacy PQA Board Chair and AMCP CEO Susan Cantrell details the “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy” report.
Hospital Pharmacy Europe
JANUARY 24, 2024
Aiming to support healthcare organisations and staff to deliver safe and effective pharmacy services, the four draft standards detail the knowledge, conduct and performance required of a chief pharmacist , or equivalent role, such as a director of pharmacy.
PQA
FEBRUARY 9, 2024
Join us as we head back to Baltimore for the 2024 PQA Annual Meeting, May 14-16! We also highlight our members' perspectives on patient reported outcomes, pharmacy consultation and pharmacy care management services. Enhance the impact of your attendance by becoming a sponsor of the meeting.
Hospital Pharmacy Europe
MARCH 28, 2024
The theme of World Pharmacists Day 2024 on 25 September will be ‘Pharmacists: meeting global health needs’, the International Pharmaceutical Federation (FIP) has announced. Commenting on the upcoming campaign, Paul Sinclair, president of FIP, said: ‘The pharmacy profession has achieved so much in improving health and wellbeing.
Digital Pharmacist
OCTOBER 6, 2023
The Prescription Drug Reform Act aims to regulate pharmacy benefit managers (PBMs) and pharmaceutical manufacturers in the state. This blog post breaks down the key aspects of the Prescription Drug Reform Act and how it affects pharmacies in Florida. Contract Changes: PBMs cannot unilaterally change contract terms with pharmacies.
Hospital Pharmacy Europe
FEBRUARY 15, 2024
‘Steady progress’ has been made across different pharmacy settings in the 12 months since the launch of the ‘10-year Vision for Pharmacy Professional Practice’, the Royal Pharmaceutical Society (RPS) has said.
PQA
APRIL 19, 2024
-- Carolyn Lockwood, RN, MSN, Director of Performance Measurement Educating Patients on Polypharmacy Polypharmacy is growing, according to the IQVIA Institute for Human Data Sciences’ Global Use of Medicines report for 2024. PQA's 2nd Quarter 2024 Stakeholder Advisory Meeting is June 5, 1:00-1:30 pm ET.
Hospital Pharmacy Europe
JULY 27, 2023
Progress on Government commitments to support both hospital and community pharmacy services in England ‘require improvement’, an expert panel commissioned by the parliamentary Health and Social Care Committee has found.
DiversifyRx
JANUARY 31, 2024
Don’t let the rule your pharmacy or ruin your profits. Here’s a rundown of the 6 essential Pharmacy Profit Pillars crucial for a thriving, financially successful pharmacy with a healthy cash flow. If you are like most independent pharmacies, then over 90% of revenue likely flows through a PBM.
The FDA Law Blog
MARCH 24, 2024
By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103).
PQA
MARCH 8, 2024
Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process. Expanding clinical interventions is a great way for independent pharmacies to begin increasing their revenue. prior to the PQA Leadership Summit.
Hospital Pharmacy Europe
NOVEMBER 2, 2023
A new chief pharmacy officer and deputy registrar has been appointed at the UK’s General Pharmaceutical Council (GPhC) to help provide pharmacy leadership across the organisation and ‘influence progress at an exciting and challenging time’ for the profession. Both will start their roles on 3 January 2024.
DiversifyRx
FEBRUARY 7, 2024
Your pharmacy’s data is the key to unlocking massive profit and success which is why it is so critical to focus on KPI optimization for every independent pharmacy owner. You’ll thank me for it because I love helping pharmacy owners understand and use their data and, hopefully, love it, too. AH… DATA!
Hospital Pharmacy Europe
FEBRUARY 29, 2024
Published in partnership with the profession’s charity, Pharmacist Support, the workforce and wellbeing report also sheds light on other mental health and workplace challenges faced by pharmacists across all sectors. This was compared to 86% in general practice and 93% of those working in community pharmacy.
DiversifyRx
OCTOBER 26, 2023
2024 is bringing a lot of changes for pharmacy owners. Here are three trends you should incorporate into your pharmacy for success. The pharmacy industry is no stranger to change. Constant updates to contracts, the supply chain, and patient expectations have shaped the way pharmacy owners should approach 2024 and beyond.
Digital Pharmacist
AUGUST 21, 2023
As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. 2023 Flu Vaccination Changes As we look at the 2023-2024 flu season, what’s new for this year? According to the CDC, in the 2023-2024 season, the U.S.
Omnicell
JANUARY 10, 2023
Pharmacy is one of the costliest areas in a health system, and an opportunity where digital transformation can make a significant difference in financial, operational, and, most importantly, clinical outcomes. Intelligence is foundational to establishing an Autonomous Pharmacy. Connected data is crucial.
DiversifyRx
JANUARY 18, 2024
At DiversifyRx, we’re all about pharmacy marketing. Check out our top blog picks to help amp up your pharmacy’s marketing game in 2024. This week, let’s explore a crucial pillar of Pharmacy Profit – Marketing. But we get it – pharmacy school didn’t teach you how to be a digital marketing pro.
IDStewardship
JULY 27, 2022
To learn about challenges from around the globe, we have been interviewing pharmacists at different countries about antimicrobial stewardship. I was born and raised in Birmingham, England and studied Pharmacy on the South Coast. Although, it is not without its challenges!
PQA
DECEMBER 21, 2023
Certainly, each year brings its share of opportunities and challenges, and I’m proud of our progress as an alliance. In 2024, PQA will begin research to advance the health plan measure concept for adherence or persistence to OAMs, which was the top priority of our convened experts.
PQA
AUGUST 29, 2023
PQA will begin research in 2024 to advance the health plan measure concept for adherence or persistence to OAMs. PQA can address this important gap in measurement by focusing on health plan and pharmacy measure opportunities. We look forward to your feedback on our report.
pharmaphorum
JULY 29, 2021
The challenge is, drugs in this category are often difficult to administer and very costly. Specialty pharmacies now have to be ready to not only meet patient demand, but also provide patients the support they need to secure reimbursement, properly administer the drug, and ensure adherence and optimal outcomes.
DiversifyRx
OCTOBER 5, 2023
Can You Significantly Boost Your Pharmacy’s Cash Flow in Just 90 Days? As the new quarter begins, it’s time to reflect on your pharmacy’s performance in the previous quarter. Were your plans and ideas overshadowed by the daily grind of managing your independent pharmacy?
Hospital Pharmacy Europe
NOVEMBER 23, 2023
The statement of policy emphasises the vital role of pharmacists in leading the fight against AMR and encourages collaboration between governments, policymakers and national pharmacy organisations. The post Calls for pharmacists to embrace AMR leadership in updated FIP policy statement appeared first on Hospital Pharmacy Europe.
The FDA Law Blog
APRIL 8, 2024
The White Paper notes that of the 123 drugs in shortage in January 2024, a quarter were first reported in shortage prior to 2020, with the oldest dating back to 2012, and shortages were experienced across therapeutic areas; analgesics/anesthetics (17%), anti-infective (12%), and cardiovascular (13%) products comprised 42% of shortages.
PQA
DECEMBER 15, 2022
There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures. PQA is developing a set of standard pharmacy performance measures suitable for assessing pharmacy performance and for use in value-based arrangements (VBAs).
Hospital Pharmacy Europe
NOVEMBER 23, 2023
The BGMA had previously attempted to win a place at the negotiating table for the VPAG deal to argue its case regarding off-patent medicines but failed in a High Court challenge to do so. The level of annual allowed growth in sales of branded medicines will double from 2% in 2024 to 4% by 2027.
Hospital Pharmacy Europe
FEBRUARY 16, 2024
And earlier in 2024, UK researchers identified a gene linked to heart defects in Down syndrome, offering a potential therapeutic target for DS-associated congenital heart defects. The post AI-powered personalised medicine project launches to optimise CVD treatment appeared first on Hospital Pharmacy Europe.
The Checkup by Singlecare
MARCH 1, 2024
Trying to describe the attention deficit hyperactivity disorder (ADHD) experience can be challenging. But determining whether someone needs it is challenging, and because it’s a controlled substance, getting a prescription can be, too. That’s why pharmacies are prohibited from refilling it.
PQA
DECEMBER 5, 2023
Self-nominations for the 2024 program will be accepted through Friday, December 8, via a form on the PQA website. I have a background in pharmacy. After my bachelor's in pharmacy, I decided to pursue a doctorate in health outcomes research. He has been involved in PQA’s performance measurement and research work for many years.
Hospital Pharmacy Europe
APRIL 10, 2024
These findings fed into the development and subsequent publication in January 2024 of a randomised controlled trial examining inhaler titration alongside benralizumab. We have a very educated and willing cohort of healthcare professionals in pharmacy, but we have lower confidence than some of our colleagues,’ she notes.
PQA
SEPTEMBER 8, 2023
The uniqueness of OAMs, including complex treatment regimens, variable dosing schedules, and temporary and intentional discontinuation of therapy, present distinct challenges to accurately defining and measuring adherence and persistence. Questions about the initiative can be sent to QuIRC@PQAalliance.org.
pharmaphorum
JANUARY 24, 2023
The challenge is that the overall volume of interactive engagement, whether virtual or face to face, remains down in Europe, Japan, and China on 2019 levels by between 14% and 37%. However, for large pharma, this restructuring, while painful, is not an existential challenge.
PQA
FEBRUARY 29, 2024
Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process. This one-day event will take place on Thursday, November 7, 2024, in Arlington, Va., prior to the PQA Leadership Summit.
PQA
AUGUST 21, 2023
The application window for the 2024-25 fellow cycle will open in September. Kyra Leonard, PharmD Kyra Leonard, PharmD, is the Executive Fellow at the Pharmacy Quality Alliance (PQA). A Columbus, Georgia native, Leonard completed her Doctor of Pharmacy coursework at the University of Georgia College of Pharmacy.
STAT
JULY 6, 2023
Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us. in 2024. The number of layoffs in the U.S.
pharmaphorum
SEPTEMBER 30, 2022
In March, the first advisory committee agreed with the opinion voiced by the FDA reviewer that there were doubts about the efficacy of Relyvrio, and that it would be preferable to wait for the results of an ongoing, larger study – now expected to read out in 2024. — The ALS Association (@alsassociation) September 29, 2022.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content